ID: ALA86296

Max Phase: Preclinical

Molecular Formula: C11H10ClNO2

Molecular Weight: 223.66

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccccc1-c1cc(CCl)on1

Standard InChI:  InChI=1S/C11H10ClNO2/c1-14-11-5-3-2-4-9(11)10-6-8(7-12)15-13-10/h2-6H,7H2,1H3

Standard InChI Key:  SFVUMAUIGYTCFT-UHFFFAOYSA-N

Associated Targets(non-human)

Cystic fibrosis transmembrane conductance regulator 71 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 223.66Molecular Weight (Monoisotopic): 223.0400AlogP: 3.09#Rotatable Bonds: 3
Polar Surface Area: 35.26Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.72CX LogD: 2.72
Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.75Np Likeness Score: -1.17

References

1. Sammelson RE, Ma T, Galietta LJ, Verkman AS, Kurth MJ..  (2003)  3-(2-Benzyloxyphenyl)isoxazoles and isoxazolines: synthesis and evaluation as CFTR activators.,  13  (15): [PMID:12852954] [10.1016/s0960-894x(03)00482-7]

Source